View in EDS HTML Full Text PDF Full Text

BAY 87-2243 sensitizes hepatocellular carcinoma Hep3B cells to histone deacetylase inhibitors treatment via GSK-3β activation.

Saved in:
Bibliographic Details
Title: BAY 87-2243 sensitizes hepatocellular carcinoma Hep3B cells to histone deacetylase inhibitors treatment via GSK-3β activation.
Authors: Li, Yang-Ling1,2 (AUTHOR), Rao, Ming-Jun1,2,3 (AUTHOR), Zhang, Ning-Yu4 (AUTHOR), Wu, Lin-Wen5 (AUTHOR), Lin, Neng-Ming1,2,3 (AUTHOR) lnm1013@163.com, Zhang, Chong4 (AUTHOR) zhangchong@zucc.edu.cn
Source: Experimental & Therapeutic Medicine. Jun2019, Vol. 17 Issue 6, p4547-4553. 7p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:17920981